The healthcare service sector universe is being driven by an aging population, which is driving demand for their products/services. 

On average, they trade at 12x EV/EBITDA and as high as 16x, with many now trading at 52-week highs.

At 3.3x, PHM trades at a 70% discount, yet now shows similar financial metrics as the other players. We believe this valuation gap will narrow in the coming quarters.

Maintain Buy and raise target to $0.40 (was $0.35) based on 12x our FY19 EBITDA forecast.